[Efficacy and safety of bendamustine-rituximab combination therapy for newly diagnosed indolent B-cell non-Hodgkin's lymphoma and elderly mantle cell lymphoma: a multi-center prospective phase II clinical trial in China]
【苯达莫司汀-利妥昔单抗联合治疗新诊断惰性B细胞非霍奇金淋巴瘤和老年套细胞淋巴瘤的疗效和安全性：一项在中国开展的多中心前瞻性II期临床试验】
期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.issn.0253-2727.2023.07.004
Wang, H; He, Q; Liu, D; Deng, X Z; Ma, J; Xie, L N; Sun, Z L; Liu, C; Zhao, R R; Lu, K; Chu, X X; Gao, N; Wei, H C; Sun, Y H; Zhong, Y P; Xing, L J; Zhang, H Y; Zhang, H; Xu, W W; Li, Z J
